Elevance Health, Inc. (Anthem, Inc.) 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Anthem, Inc. (now Elevance Health, Inc.) on April 26, 2017. The filing reports the company's financial results for the first quarter ended March 31, 2017, via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1) but are not detailed in the body of this 8-K document.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It serves only as a notification that Q1 2017 results have been issued.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. It explicitly states that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated April 26, 2017) for actual Q1 2017 financial figures.
- Verify the specific revenue, net income, and earnings per share reported in the press release.
- Check for any forward-looking statements or guidance updates included in the press release.
- Confirm the company's status as an emerging growth company (indicated as "No" in this filing).